• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受依前列醇治疗的肺动脉高压患者出现甲状腺肿

Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol.

作者信息

Abughazaleh Shaadi, Safdar Zeenat

机构信息

Department of Pulmonary-Critical Care Medicine, Houston Methodist Hospital, Weill Cornell College of Medicine, Houston, TX, USA.

出版信息

Case Rep Pulmonol. 2020 Jan 23;2020:1617253. doi: 10.1155/2020/1617253. eCollection 2020.

DOI:10.1155/2020/1617253
PMID:32082680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6998745/
Abstract

A 35-year-old female with pulmonary arterial hypertension (PAH) who presented with complaints of progressively worsening dysphagia, facial swelling, and shortness of breath, was found to have a large goiter. In patients treated with epoprostenol for long periods of time, thyroid disease is common. Most cases of thyroid disease describe thyrotoxicosis and hyperthyroid statues, but our case was a patient on long term IV epoprostenol presenting with a superior vena cava-syndrome (SVC) like appearance and airway compromise found to have a goiter incidentally during workup.

摘要

一名35岁患有肺动脉高压(PAH)的女性,出现进行性加重的吞咽困难、面部肿胀和呼吸急促等症状,被发现患有巨大甲状腺肿。长期使用依前列醇治疗的患者中,甲状腺疾病很常见。大多数甲状腺疾病病例描述的是甲状腺毒症和甲状腺功能亢进状态,但我们的病例是一名长期接受静脉注射依前列醇治疗的患者,其表现类似上腔静脉综合征(SVC),在检查过程中偶然发现患有甲状腺肿且气道受压。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/a5702341910a/CRIPU2020-1617253.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/1d9da6c21621/CRIPU2020-1617253.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/43ebc0c203b6/CRIPU2020-1617253.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/38499587a4da/CRIPU2020-1617253.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/a5702341910a/CRIPU2020-1617253.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/1d9da6c21621/CRIPU2020-1617253.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/43ebc0c203b6/CRIPU2020-1617253.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/38499587a4da/CRIPU2020-1617253.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/6998745/a5702341910a/CRIPU2020-1617253.004.jpg

相似文献

1
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol.接受依前列醇治疗的肺动脉高压患者出现甲状腺肿
Case Rep Pulmonol. 2020 Jan 23;2020:1617253. doi: 10.1155/2020/1617253. eCollection 2020.
2
A Case of Giant Goiter Associated with Airway Stenosis Caused by Long-Term Intravenous Epoprostenol Therapy for Idiopathic Pulmonary Arterial Hypertension.一例因特发性肺动脉高压长期静脉输注依前列醇治疗导致巨大甲状腺肿合并气道狭窄的病例。
J Clin Med. 2023 Oct 4;12(19):6359. doi: 10.3390/jcm12196359.
3
Thyroid Dysfunction in Patients with Pulmonary Artery Hypertension (PAH): The Effect of Therapies Affecting the Prostanoid Pathway.肺动脉高压(PAH)患者的甲状腺功能障碍:影响前列环素途径的治疗的影响。
Lung. 2019 Dec;197(6):761-768. doi: 10.1007/s00408-019-00283-8. Epub 2019 Nov 6.
4
Effect of epoprostenol on the thyroid gland: enlargement and secretion of thyroid hormone.依前列醇对甲状腺的影响:甲状腺肿大及甲状腺激素分泌
Endocr Pract. 2009 Mar;15(2):116-21. doi: 10.4158/EP.15.2.116.
5
Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels.持续静脉输注依前列醇治疗的慢性肺动脉高压患者的中心静脉血氧饱和度监测:与血流动力学测量及血浆脑钠肽水平的相关性
Chest. 2007 Sep;132(3):786-92. doi: 10.1378/chest.07-0694. Epub 2007 Jul 23.
6
Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension.依前列醇和内皮素受体拮抗剂治疗对肺动脉高压患者甲状腺毒症发生发展的影响。
Endocr J. 2017 Dec 28;64(12):1173-1180. doi: 10.1507/endocrj.EJ17-0155. Epub 2017 Sep 9.
7
Superior vena cava syndrome and tracheal obstruction due to multinodular goiter.结节性甲状腺肿导致的上腔静脉综合征和气管梗阻
Head Neck. 1994 Jan-Feb;16(1):72-4. doi: 10.1002/hed.2880160114.
8
Superior Vena Cava Syndrome in Conjunction with Pulmonary Vasculature Compromise: A Case Study and Literature Review.上腔静脉综合征合并肺血管系统受累:病例报告及文献综述
Am J Case Rep. 2018 Oct 17;19:1237-1240. doi: 10.12659/AJCR.910165.
9
Superior vena cava syndrome caused by a benign retrosternal multinodular goiter.由良性胸骨后多结节性甲状腺肿引起的上腔静脉综合征。
J Am Osteopath Assoc. 1997 Jul;97(7):409-10. doi: 10.7556/jaoa.1997.97.7.409.
10
[Characteristics of spectra of superior vena cava flow Doppler velocities in pulmonary arterial hypertension].[肺动脉高压患者上腔静脉血流多普勒速度频谱特征]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Jun;34(6):543-9.

引用本文的文献

1
A Case of Giant Goiter Associated with Airway Stenosis Caused by Long-Term Intravenous Epoprostenol Therapy for Idiopathic Pulmonary Arterial Hypertension.一例因特发性肺动脉高压长期静脉输注依前列醇治疗导致巨大甲状腺肿合并气道狭窄的病例。
J Clin Med. 2023 Oct 4;12(19):6359. doi: 10.3390/jcm12196359.

本文引用的文献

1
Effect of treatment with epoprostenol and endothelin receptor antagonists on the development of thyrotoxicosis in patients with pulmonary arterial hypertension.依前列醇和内皮素受体拮抗剂治疗对肺动脉高压患者甲状腺毒症发生发展的影响。
Endocr J. 2017 Dec 28;64(12):1173-1180. doi: 10.1507/endocrj.EJ17-0155. Epub 2017 Sep 9.
2
Trends and Outcomes of Pulmonary Arterial Hypertension-Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012.美国肺动脉高压相关住院治疗的趋势与结果:对2001年至2012年全国住院患者样本数据库的分析
JAMA Cardiol. 2016 Dec 1;1(9):1021-1029. doi: 10.1001/jamacardio.2016.3591.
3
Scope of problem of pulmonary arterial hypertension.
肺动脉高压的问题范围。
Am J Med. 2015 Aug;128(8):844-51. doi: 10.1016/j.amjmed.2015.03.007. Epub 2015 Mar 27.
4
Pulmonary arterial hypertension: epidemiology and registries.肺动脉高压:流行病学和注册研究。
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D51-9. doi: 10.1016/j.jacc.2013.10.023.
5
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.肺动脉高压英国和爱尔兰注册研究:发病肺动脉高压的人口统计学、流行病学和生存率变化。
Am J Respir Crit Care Med. 2012 Oct 15;186(8):790-6. doi: 10.1164/rccm.201203-0383OC. Epub 2012 Jul 12.
6
The changing picture of patients with pulmonary arterial hypertension in the United States: how REVEAL differs from historic and non-US Contemporary Registries.美国肺动脉高压患者的变化情况:REVEAL 与历史和非美国当代注册研究的不同之处。
Chest. 2011 Jan;139(1):128-37. doi: 10.1378/chest.10-0075. Epub 2010 Jun 17.
7
Effect of epoprostenol on the thyroid gland: enlargement and secretion of thyroid hormone.依前列醇对甲状腺的影响:甲状腺肿大及甲状腺激素分泌
Endocr Pract. 2009 Mar;15(2):116-21. doi: 10.4158/EP.15.2.116.
8
Pulmonary arterial hypertension and thyroid disease.肺动脉高压与甲状腺疾病。
J Bras Pneumol. 2009 Feb;35(2):179-85. doi: 10.1590/s1806-37132009000200012.
9
Pulmonary arterial hypertension in France: results from a national registry.法国肺动脉高压:一项全国性登记研究的结果
Am J Respir Crit Care Med. 2006 May 1;173(9):1023-30. doi: 10.1164/rccm.200510-1668OC. Epub 2006 Feb 2.